Business Context and Reporting Period
This Form 8-K was filed by NanoVibronix, Inc. on May 3, 2017. The report details the company's continued execution of a "Bridge Financing" arrangement to raise capital through convertible debt and warrants. Note: The input metadata references "Envue Medical, Inc.," but the filing text explicitly identifies the registrant as NanoVibronix, Inc.
Key Financial Metrics and Transaction Details
- Capital Raised: $130,000 received on May 3, 2017, from two accredited investors.
- Total Bridge Financing: Cumulative proceeds reached $230,000 (including $100,000 raised on March 23, 2017).
- Instrument Terms: Convertible promissory notes with a 6% annual interest rate.
- Warrants Issued: 52,000 warrants issued with a seven-year term and an exercise price of $5.90 per share.
- Maturity: Due on the earlier of the 5-year anniversary of issuance or the completion of a "Qualified Financing" (equity raise of at least $2,000,000).
Material Changes and Conversion Mechanics
The filing reports a material increase in short-term debt and potential equity dilution. Key conversion features include:
- Conversion Price: Upon maturity or a Qualified Financing, notes convert at the lesser of 80% of the Qualified Financing price (or estimated company value) or the $5.90 cap.
- Change of Control: Investors may elect cash repayment or conversion at a discount (80% of implied value or $5.90 cap) in the event of a change of control.
- Ownership Cap: Warrant exercise is limited to prevent beneficial ownership exceeding 9.99% of outstanding common stock.
Outlook, Risks, and Contingencies
Management's immediate focus is on securing a "Qualified Financing" of at least $2,000,000 to trigger the conversion of the current debt. The filing does not provide specific revenue guidance or operational outlook beyond the financing activity. Risks include the potential for significant dilution to existing shareholders due to the 20% discount feature on conversion and the obligation to repay principal plus accrued interest if a Qualified Financing is not achieved within five years.
Investor Verification Checklist
- Verify the total outstanding principal under the Bridge Financing ($230,000 as of May 3, 2017).
- Confirm the current status of the search for a Qualified Financing ($2M+ equity raise).
- Review the fully diluted share count to assess the impact of the 52,000 new warrants and potential note conversion.
- Check for any subsequent filings regarding the March 23, 2017 tranche or additional debt issuances.